Table 2.
Societal costs of hepatitis B virus-related diseases in 2005 (million KRW, %)
Liver disease | Direct costs | Indirect costs | Total |
---|---|---|---|
Chronic hepatitis B | 134,528 | 330,640 | 465,167 (24) |
Cirrhosis | 112,284 | 421,165 | 433,446 (27.8) |
Hepatocellular carcinoma | 173,084 | 690,856 | 863,940 (44.6) |
Liver transplantation | 54,746 | 19,888 | 74,635 (3.9) |
Total costs | 474,642 | 1,462,549 | 1,937,191 (100) |
Values are presented as number (%). Adapted from Yang et al. [42], with permission from Springer Nature.
KRW, Korea won.